Search

everythinglearnresearchcommunity

for

Search:↓

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

The COVID-19 vaccine is viewed more negatively and causes more side effects than the flu vaccine in Korean patients with lupus.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Nanoparticles can deliver vaccines through hair follicles, triggering immune responses and providing protection.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Smaller nanoemulsions can penetrate skin and hair follicles better, which may be useful for delivering drugs and vaccines through the skin.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Microneedles are effective for drug delivery, vaccinations, fluid extraction, and treating hair loss, with advancements in manufacturing like 3D printing.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

The document concludes that the first book on mesotherapy lacks convincing evidence, the second book is good for beginners in facial rejuvenation, and the third book is valuable for understanding complications in skin surgery.

Activating TLR5 in the gut can extend lifespan and improve health in aged mice.

Older men with late-onset lupus have a higher mortality rate than women.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Micro-needling effectively improves wrinkles, scars, and hair growth, but proper technique and safety are important.